{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:39:37Z","timestamp":1773365977907,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015501","name":"Qu\u1ef9 \u0110\u1ed5i m\u1edbi s\u00e1ng t\u1ea1o Vingroup","doi-asserted-by":"publisher","award":["VINIF.2021"],"award-info":[{"award-number":["VINIF.2021"]}],"id":[{"id":"10.13039\/501100015501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015501","name":"Qu\u1ef9 \u0110\u1ed5i m\u1edbi s\u00e1ng t\u1ea1o Vingroup","doi-asserted-by":"publisher","award":["DA00212"],"award-info":[{"award-number":["DA00212"]}],"id":[{"id":"10.13039\/501100015501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrep.2025.102343","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T23:05:31Z","timestamp":1762470331000},"page":"102343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating miRNAs combined with AFP improve diagnostic accuracy for HBV-associated hepatocellular carcinoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Ngo","family":"Dieu Hoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao Phuong","family":"Giang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thi","family":"Thu Hien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dang Thi","family":"Ngoc Dung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai Thanh","family":"Binh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngo Tat","family":"Trung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Thi","family":"Thanh Huyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-8810","authenticated-orcid":false,"given":"Hoang Van","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirumalaisamy P.","family":"Velavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Huu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nghiem Xuan","family":"Hoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbrep.2025.102343_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"20","key":"10.1016\/j.bbrep.2025.102343_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012541","article-title":"Cytotoxic T cell expression of leukocyte-associated immunoglobulin-like Receptor-1 (LAIR-1) in viral hepatitis C-Mediated hepatocellular carcinoma","volume":"23","author":"Hammad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17998\/jlc.2024.03.13","article-title":"Changing etiology and epidemiology of hepatocellular carcinoma: asia and worldwide","volume":"24","author":"Kim","year":"2024","journal-title":"J. Liver Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.bbrep.2025.102343_bib4","article-title":"Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management","volume":"12","author":"Samant","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102343_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/iub.597","article-title":"Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor","volume":"64","author":"Swellam","year":"2012","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib6","first-page":"32","article-title":"Updates on the diagnosis and management of hepatocellular carcinoma","volume":"11","author":"Raees","year":"2021","journal-title":"Euroasian J. Hepatogastroenterol."},{"issue":"20","key":"10.1016\/j.bbrep.2025.102343_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39489","article-title":"Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: integrating literature review and bioinformatics analysis for therapeutic insights","volume":"10","author":"Rahdan","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.bbrep.2025.102343_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","article-title":"Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma","volume":"28","author":"Hanif","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejrad.2006.11.003","article-title":"Cirrhosis: CT and MR imaging evaluation","volume":"61","author":"Brancatelli","year":"2007","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib10","first-page":"51","article-title":"Advancements in the diagnosis of hepatocellular carcinoma","volume":"3","author":"Parra","year":"2023","journal-title":"Int. J. Transl. Med."},{"key":"10.1016\/j.bbrep.2025.102343_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1353547","article-title":"Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"11","author":"Alemayehu","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"Pt 2","key":"10.1016\/j.bbrep.2025.102343_bib12","article-title":"CCDC144NL-AS1\/hsa-miR-143-3p\/HMGA2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision","volume":"253","author":"Abd El Fattah","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrep.2025.102343_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122946","article-title":"Unraveling the ncRNA landscape that governs colorectal cancer: a roadmap to personalized therapeutics","volume":"354","author":"Hamdy","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102343_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/0115665232274223231017052707","article-title":"FIGNL1 promotes hepatocellular carcinoma formation via remodeling ECM-receptor interaction pathway mediated by HMMR","volume":"24","author":"Wang","year":"2024","journal-title":"Curr. Gene Ther."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102343_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0037-1602695","article-title":"Analysis of CYP1B1 gene mutations in patients with primary congenital glaucoma","volume":"6","author":"Chouiter","year":"2017","journal-title":"J. Pediatr. Genet."},{"key":"10.1016\/j.bbrep.2025.102343_bib16","article-title":"Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing Ferredoxin 1 : miR-3130-5p enhances HCC growth via inhibiting FDX1","volume":"17","author":"Xu","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.bbrep.2025.102343_bib17","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.7150\/jca.26101","article-title":"A miRNA combination as promising biomarker for hepatocellular carcinoma diagnosis: a study based on bioinformatics analysis","volume":"9","author":"Ji","year":"2018","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102343_bib18","first-page":"13","article-title":"MicroRNAs in the pathogenesis of hepatocellular carcinoma: a review","author":"Morishita","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102343_bib19","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/liv.15682","article-title":"miR-21-5p promotes NASH-related hepatocarcinogenesis","volume":"43","author":"Rodrigues","year":"2023","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib20","first-page":"39","article-title":"miR-34a-5p plays an inhibitory role in hepatocellular carcinoma by regulating target gene VEGFA","volume":"44","author":"Niu","year":"2022","journal-title":"Malays. J. Pathol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib21","first-page":"257","article-title":"Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models","volume":"41","author":"Yu","year":"2019","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.bbrep.2025.102343_bib22","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3390\/v14112571","article-title":"Comparisons of viral etiology and outcomes of hepatocellular carcinoma undergoing liver resection between Taiwan and Vietnam","volume":"14","author":"Nguyen-Dinh","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","article-title":"Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment","volume":"26","author":"Gudivada","year":"2025","journal-title":"Curr. Genom."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102343_bib24","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.18632\/oncotarget.23332","article-title":"Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis","volume":"9","author":"Guo","year":"2018","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.bbrep.2025.102343_bib25","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.7150\/jca.32833","article-title":"Diagnostic value of circulating microRNAs in Hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"10","author":"Jin","year":"2019","journal-title":"J. Cancer"},{"issue":"252","key":"10.1016\/j.bbrep.2025.102343_bib26","first-page":"1","article-title":"Summary health statistics for U.S. adults: National health interview survey, 2010","author":"Schiller","year":"2012","journal-title":"Vital Health Stat 10"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102343_bib27","first-page":"2699","article-title":"Serum miRNA panel in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma","volume":"17","author":"Khairy","year":"2016","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2011.04.026","article-title":"Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma","volume":"56","author":"Tomimaru","year":"2012","journal-title":"J. Hepatol."},{"issue":"30","key":"10.1016\/j.bbrep.2025.102343_bib29","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102343_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196081","article-title":"Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma","volume":"13","author":"Tat Trung","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102343_bib31","first-page":"1466","article-title":"MicroRNA-21 as a diagnostic marker for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"35","author":"Juan","year":"2019","journal-title":"Pakistan J. Med. Sci."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102343_bib32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/1354750X.2021.1955976","article-title":"Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinoma:a meta-analysis","volume":"26","author":"Huiying","year":"2021","journal-title":"Biomarkers"},{"issue":"11","key":"10.1016\/j.bbrep.2025.102343_bib33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14737159.2022.2145189","article-title":"Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"22","author":"Ana Karla da Silva F","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102343_bib34","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3390\/ijms24043157","article-title":"Diagnostic significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and ratios in hepatocellular carcinoma on top of liver cirrhosis in HCV-infected patients","volume":"24","author":"Mona","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102343_bib35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.7150\/jca.57205","article-title":"Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma","volume":"13","author":"Shuying","year":"2022","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102343_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7150\/jca.79593","article-title":"Prognostic MicroRNA fingerprints predict recurrence of early-stage hepatocellular carcinoma following hepatectomy","volume":"14","author":"Victor Chun Lam","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbrep.2025.102343_bib37","first-page":"25","article-title":"MicroRNAs as plasma biomarkers of hepatocellular carcinoma in patients with liver cirrhosis\u2014A cross-sectional study","author":"Robin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102343_bib38","doi-asserted-by":"crossref","first-page":"101716","DOI":"10.1016\/j.xcrm.2024.101716","article-title":"Five miRNAs identified in fucosylated extracellular vesicles as non-invasive diagnostic signatures for hepatocellular carcinoma","volume":"5","author":"Boan","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbrep.2025.102343_bib39","series-title":"miR-122 and miR-21 as Clinical Biomarkers in Hepatocellular Carcinoma: a Review","author":"Nishant","year":"2023"},{"issue":"12","key":"10.1016\/j.bbrep.2025.102343_bib40","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1002\/hep4.2096","article-title":"Sex-specific analysis of microRNA profiles in HBV-associated cirrhosis by small RNA-sequencing","volume":"6","author":"Kristy Kwan-Shuen","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"14","key":"10.1016\/j.bbrep.2025.102343_bib41","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.3390\/ijms25147858","article-title":"Analysis of carcinogenic involvement of MicroRNA pattern in peripheral non-cancerous tissues and chronic viral liver injury","volume":"25","author":"Tomohiro","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.bbrep.2025.102343_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411544","article-title":"Gender differences and miRNAs expression in cancer: implications on prognosis and susceptibility","volume":"24","author":"Caserta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102343_bib43","first-page":"13","article-title":"Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma","author":"Ngo Tat","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102343_bib44","first-page":"10","article-title":"Potential role of circulating microRNA-21 for hepatocellular carcinoma diagnosis: a meta-analysis","author":"Qibin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.102343_bib45","article-title":"Diagnostic accuracy of circulating miRNAs to discriminate hepatocellular carcinoma from liver cirrhosis: a systematic review and meta-analysis","author":"Ermiyas","year":"2024","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102343_bib46","first-page":"34","article-title":"MicroRNA 21as a novel biomarker in hepatitis C virus-related hepatocellular carcinoma","author":"Maha Assem","year":"2022","journal-title":"Egyptian J. Internal Med."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825004303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825004303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:15:10Z","timestamp":1773321310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825004303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S2405580825004303"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102343","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating miRNAs combined with AFP improve diagnostic accuracy for HBV-associated hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102343"}}